Since Synaptamine was released, manufacturing, technology, and research on additional ingredients has improved over time, and significantly improved delivery modalities have been created. As a result of these innovations, Sanus Biotech has developed and patented several of its own formulations, the first of which is called Cerveau. Cerveau has been developed to address the symptoms associated with low dopamine levels, and will initially be released as a sublingual tablet in three specially-formulated versions of “original,” “addiction”, and “memory”.
While Cerveau’s initial release will be in sublingual form, liquid (including a beverage), capsules, stick packs, chewable, and lozenges are also in the works.
Here are the ingredients in Cerveau:
Original Formula | 1.5 mg | Dose 1 tablet per day
Vitamin B6, L-Tyrosine USP, L-Glutamine, Rhodiola, Root Extract 3% Rosavin, Griffonia simplicifolia Seed Extract, 5-HTP, DL-Phenylalanine, Passion Flower Aerial Extract, N-Acetyl-Cysteine, Arabinogalactan, Mucuna pruriens seed extract, L-Dopa, L-Theanine, D-Ribose, Phosphatidyl Serine, SAM-e.
A critical element to the efficacy of Cerveau is how it is manufactured. Our goal is to deliver a product that breaks the Blood Brain Barrier (BBB) and avoids the “gut,” where products are broken down by the digestive system and lose a substantial amount of their efficacy. The BBB is a highly selective semipermeable membrane barrier that separates the circulating blood from the brain and extracellular fluid in the central nervous system. The BBB is formed by brain endothelial cells and it allows the passage of water, some gases, and lipid-soluble molecules by passive diffusion, as well as the selective transport of molecules such as glucose and amino acids that are crucial to neural function.
Sanus Biotech has partnered with one of the leading nanotechnology companies in the country. Research is showing that Nanotechnology helps in the transfer of drugs across the BBB. Delivering drugs across the blood–brain barrier is one of the most promising applications of nanotechnology in clinical neuroscience. Nanoparticles could potentially carry out multiple tasks in a predefined sequence, which is very important in the delivery of drugs across the blood–brain barrier.
Nanoparticle manufacturers generally face challenges in three areas:
Through a propriety manufacturing process, our partner has overcome the common nanotech challenges.
*Cerveau will be priced at $38.99 for a 30-day supply. Price is subject to change. Wholesale pricing will be available. Contact us at firstname.lastname@example.org for wholesale information.
Comments will be approved before showing up.
Setting a goal and reaching it gives you a sense of accomplishment and triggers the reward system (ie. DOPAMINE) in your brain. And—as you know—when dopamine is released, you feel happy. Thus goal setting can be a key component in giving you an on-going sense of wellbeing.